Drug Self-Administration Markets to 2016: Devices, Drugs, Markets, Strategies and Forecasts

NEW YORK, Jan. 18, 2012  /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Drug Self-Administration Markets to 2016: Devices, Drugs, Markets, Strategies and Forecasts

http://www.reportlinker.com/p0761243/Drug-Self-Administration-Markets-to-2016-Devices-Drugs-Markets-Strategies-and-Forecasts.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

While alternative methods for delivering therapeutics to patients have had some notable successes, most drugs continue to be delivered orally. Because they cannot tolerate the first-pass metabolism of the digestive tract, the recent escalation in new biological drugs, including antibodies and recombinant proteins, is placing renewed emphasis on alternate delivery technologies. Now a number of factors are converging to create both risk and opportunity for drug makers and their delivery device partners. These include new classes of drugs for previously refractory conditions, the growing trend toward self-administration for chronic diseases, shifting patient demographics in industrial countries, caregiver safety legislation, and continued pressure to control healthcare costs. These factors are giving rise to a new generation of sophisticated, application-specific injection, inhalation and transdermal drug products designed to satisfy caregiver and patient preferences while addressing managed care initiatives and the formulation limitations of new classes of therapeutic drugs. Because of their ability to safely and reliably satisfy treatment protocols and compliance goals, non-oral drug delivery products will have a significant impact on the future of drug self-administration.

Highlights

• Analyzes therapeutic demand drivers and evaluates commercial drug products in more than two dozen major self-administration therapeutic segments

• Analyzes design factors, material selection issues, technologies and market development issues for injection devices, inhalation devices and transdermal drug products designed for self-administration

• Charts product data, market share, and forecasts to 2016

• Profiles self-administration drug product and device participants, their product development activities, business strategies, and corporate alliances and affiliations

Executive Summary

Evolving Drug Market Factors

Chronic Disease and Self-administration

Managed Care and Prescribing Trends

Drug Self-Administration Demand Factors

Shifting Patient Demographics

Biological Drug Proliferating

Delivery Device Technology & Evolving

Drug Self-Administration Product Segments and Market Drivers Injectable Drug Self-Administration Products

Market Sector DynamicsThe Shift to Prefilled DevicesDevice Selection FactorsMarket Segmentation & CostProduct Features & Ease of UseCustom Device Designs & BrandingPrefilled Syringes (PFS)Glass PFSPlastic PFSProspects for Autoinjector sKey PFS Therapeutic SegmentsThe PFS Supply ChainPFS Supplier ProfilesPen InjectorsReusable PensDisposable PensKey Pen Injector Therapeutic SegmentsThe Top Ten Pen Injector Drug ProductsFive Segments Driving Pen Injector GrowthPen Injector Company ProfilesNeedle-free Injectors (NFI)Reusable NFIDisposableCompetitive NFI Therapeutic SegmentsNeedle-free Company Profiles

Inhaled Drug Self-Administration Products

Market Sector DynamicsThe Upper Respiratory MarketEstablished Therapeutic TargetsDual Drug InhalersThe Systemic/Deep Lung MarketEstablished MarketsEmerging TherapiesInhaler Technology and Market ProspectsInhaler Product SegmentsDry Powder InhalersDevice Design FactorsPowder TechnologyPackaging IssuesDPI Device Company ProfilesMetered Dose InhalersBasic DesignsBreathe Actuated DesignsMDI Device Company ProfilesNebulizersEstablished Nebulizer TherapiesEvolving Nebulizer TechnologyNebulizer Device Company ProfilesPerformance FactorsBioavailabilityDose ReproducibilityActive Compound Stability

Transdermal Drug Products

Market Sector DynamicsTraditional Patch MarketsEmerging MarketsTransdermal Patch Market DriversPrescription Patch Design & TechnologyPassive Patch ArchitecturePassive Transdermal Patch DesignPassive Patch ConstructionActive Transport Patch TechnologiesIontophoresisElectroporationMicroporationMechanical ArraysRadio FrequencyThermal/HeatUltrasoundPrescription Patch Development FactorsKey Transdermal Therapeutic MarketsTransdermal Product Company Profiles

Drug Self-Administration – Therapeutic Sector Analysis & Forecasts

ADHDAnticoagulantsArthritisAsthma/COPDCardiovascularContraceptionCystic FibrosisDiabetesHematopoieticsHepatitisHormone Therapy/ReplacementMultiple SclerosisNeurologyOsteoporosisPain ManagementPsoriasisSexual Health

To order this report:Drug Delivery Technology Industry: Drug Self-Administration Markets to 2016: Devices, Drugs, Markets, Strategies and Forecasts

More  

Market Research Report

Check our  

Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker